AI-Driven Mitosis Profiling
MitPro®: the new wave of mitosis analysis
Counting mitotic figures, a crucial criterion for cancer grading, is inherently time-consuming and subject to significant inter-observer variability. MitPro® is an AI-driven solution for precise mitosis quantification and profiling, enhancing pathology workflows by increasing reliability, speed, and consistency of analysis.
Compatible with H&E whole-slide images (WSIs), MitPro® processes the entire slide, detects all mitotic figures, and identifies the three regions with the highest counts (hotspots). Pathologists can use these suggested hotspots or define their own custom regions for assessment.
This tool is currently for research use only and is undergoing CE-IVDR regulatory approval.
Next-generation mitosis profiling
Reduced time required for analysis
Significant time savings with AI-powered counting, as opposed to manual alternatives
Improved consistency in mitosis counting
AI-assisted mitosis counting leads to improved consistency between pathologists.
Supports a range of tumour types
Validated across breast, lung, melanoma, soft tissue sarcoma, leiomyoma, neuroendocrine tumours, glioblastoma, meningioma, thyroid, and retinoblastoma.
Seamless integration with existing workflows
MitPro® is a vendor-agnostic solution designed to integrate seamlessly with pathology image management systems, ensuring smooth adoption of AI into existing digital workflows.
Accelerating the adoption of of AI-powered mitosis analysis
Histofy, a company specialising in developing transparent AI for pathology, today announces a project to develop an AI-powered system that provides precise quantification …